"Bertis patented innovative screening method allows
early diagnosis of breast cancer with a single drop of blood."
Innovative screening method
Bertis’s patented, innovative early breast cancer screening technology improves
on the accuracy levels of conventional screening methods and detects breast cancer
as early as Stage 1 with only a drop of blood, vastly increasing the chance for
timely effective treatment.
"Bertis is a leading proteomics-based molecular
Bertis is a proteomics-based molecular diagnostics biotechnology company.
By using a high-performance mass spectrometry technology that can quantify extremely small amount of protein, we identify potential diagnostic biomarkers
in the body.
"Bertis is dedicated to build health and happiness of humanity by realizing early diagnosis medicine." LEARN MORE